GB1572406A - Creation of Inventions and Patents with Artificial Intelligence

GB1572406A – Aliphatic phosphonic/carboxylic acid compounds
– Google Patents

GB1572406A – Aliphatic phosphonic/carboxylic acid compounds
– Google Patents
Aliphatic phosphonic/carboxylic acid compounds

Download PDF
Info

Publication number
GB1572406A

GB1572406A
GB54106/76A
GB5410676A
GB1572406A
GB 1572406 A
GB1572406 A
GB 1572406A
GB 54106/76 A
GB54106/76 A
GB 54106/76A
GB 5410676 A
GB5410676 A
GB 5410676A
GB 1572406 A
GB1572406 A
GB 1572406A
Authority
GB
United Kingdom
Prior art keywords
compound
formula
acid
mixture
compounds
Prior art date
1976-12-24
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Expired

Application number
GB54106/76A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Novartis AG

Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
1976-12-24
Filing date
1976-12-24
Publication date
1980-07-30

1976-12-24
Application filed by Ciba Geigy AG
filed
Critical
Ciba Geigy AG

1976-12-24
Priority to GB54106/76A
priority
Critical
patent/GB1572406A/en

1977-12-20
Priority to DE19772756678
priority
patent/DE2756678A1/en

1977-12-23
Priority to FR7738948A
priority
patent/FR2375245A1/en

1977-12-23
Priority to NL7714372A
priority
patent/NL7714372A/en

1977-12-23
Priority to BE183802A
priority
patent/BE862274A/en

1977-12-24
Priority to JP15633277A
priority
patent/JPS5379822A/en

1979-02-26
Priority to US06/015,016
priority
patent/US4208344A/en

1979-10-22
Priority to US06/087,133
priority
patent/US4265769A/en

1980-07-30
Publication of GB1572406A
publication
Critical
patent/GB1572406A/en

Status
Expired
legal-status
Critical
Current

Links

Espacenet

Global Dossier

Discuss

Classifications

C—CHEMISTRY; METALLURGY

C23—COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; CHEMICAL SURFACE TREATMENT; DIFFUSION TREATMENT OF METALLIC MATERIAL; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL; INHIBITING CORROSION OF METALLIC MATERIAL OR INCRUSTATION IN GENERAL

C23F—NON-MECHANICAL REMOVAL OF METALLIC MATERIAL FROM SURFACE; INHIBITING CORROSION OF METALLIC MATERIAL OR INCRUSTATION IN GENERAL; MULTI-STEP PROCESSES FOR SURFACE TREATMENT OF METALLIC MATERIAL INVOLVING AT LEAST ONE PROCESS PROVIDED FOR IN CLASS C23 AND AT LEAST ONE PROCESS COVERED BY SUBCLASS C21D OR C22F OR CLASS C25

C23F11/00—Inhibiting corrosion of metallic material by applying inhibitors to the surface in danger of corrosion or adding them to the corrosive agent

C23F11/08—Inhibiting corrosion of metallic material by applying inhibitors to the surface in danger of corrosion or adding them to the corrosive agent in other liquids

C23F11/10—Inhibiting corrosion of metallic material by applying inhibitors to the surface in danger of corrosion or adding them to the corrosive agent in other liquids using organic inhibitors

C23F11/167—Phosphorus-containing compounds

C23F11/1676—Phosphonic acids

C—CHEMISTRY; METALLURGY

C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE

C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE

C02F5/00—Softening water; Preventing scale; Adding scale preventatives or scale removers to water, e.g. adding sequestering agents

C02F5/08—Treatment of water with complexing chemicals or other solubilising agents for softening, scale prevention or scale removal, e.g. adding sequestering agents

C02F5/10—Treatment of water with complexing chemicals or other solubilising agents for softening, scale prevention or scale removal, e.g. adding sequestering agents using organic substances

C02F5/14—Treatment of water with complexing chemicals or other solubilising agents for softening, scale prevention or scale removal, e.g. adding sequestering agents using organic substances containing phosphorus

C—CHEMISTRY; METALLURGY

C07—ORGANIC CHEMISTRY

C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM

C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System

C07F9/02—Phosphorus compounds

C07F9/28—Phosphorus compounds with one or more P—C bonds

C07F9/38—Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se)

C07F9/3804—Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se) not used, see subgroups

C07F9/3808—Acyclic saturated acids which can have further substituents on alkyl

C—CHEMISTRY; METALLURGY

C07—ORGANIC CHEMISTRY

C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM

C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System

C07F9/02—Phosphorus compounds

C07F9/28—Phosphorus compounds with one or more P—C bonds

C07F9/38—Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se)

C07F9/40—Esters thereof

C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic

C07F9/4006—Esters of acyclic acids which can have further substituents on alkyl

Description

PATENT SPECIFICATION ( 11) 1 572 406
( 21) Application No 54106/76 ( 22) Filed 24 Dec 1976 ( 23) Complete Specification filed 25 Nov1977 ( 19) ( 44) Complet Specification published 30 July 1980 ( 51) INT CL 3 C 07 F 9/38; C 02 F 5/14; C 23 F 11/16 ( 52) Index at acceptance C 2 P 3 Bll A 3 B 11 l B 3 B 12 A 3 B 14 A 3 B 16 3 B 19 A 3 B 19 B 3 B 19 E 5 A 5 B 7 9 C 1 C 202 203 204 220 222 223 230 251 252 253 254 315 324 405 463 A ( 72) Inventors JOHN GREY DINGWALL, BARRY COOK and ALAN MARSHALL ( 54 i ALIPHATIC PHOSPHONIC/CARBOXYLIC ACID COMPOUNDS ( 71) We, CIBA-GEIGY AG, a Swiss body Corporate, of Basle, Switzerland, do hereby declare the invention, for which we pray that a patent may be granted to us, and the method by which it is to be performed, to be particularly
described in and by the following statement:-
The present invention relates to new phosphonic/carboxylic acids having value as additives to aqueous systems and processes for their preparation.
According to the present invention there is provided a compound or mixture of compounds of the general formula:
t H R 2 H R 5 H l I I I HOOC C -C-C-C C -COOH I Rom R 3 R 4 P=O R 6/n o % H H in which m and N may be 0 or 1 but both cannot be 1, R’, R 2, R 3, R 4, R” and R’ are 10 independently H or CH 3, and the water-soluble inorganic or organic salts thereof, with the proviso that when m is 1, at least one of R 1, R 2, R 3, R 4, R 5 must be CH 3, and when m and N are both 0, R 2 and R 3 are each methyl and R 4 and R 5 have their previous significance.
Examples of compounds of formula I when nm= 1 and n= 0 are as follows: 15 2-methyl-2-phosphonoadipic acid 3-methyl-2-phosphonoadipic acid 4-methyl-2-phosphonoadipic acid 5-methyl-2-phosphonoadipic acid 2,4-dimethyl-2-phosphonoadipic acid 20 2,3-dimethyl-2-phosphonoadipic acid 4,4-dimethyl-2-phosphonoadipic acid 2,4,4-trimethyl-2-phosphonoadipic acid 2,4,4,5-tetramethyl-2-phosphonoadipic acid Examples of compounds of formula I when m 0 and N = 1 are as follows: 25 3-phosphonoadipic acid 2-methyl-3-phosphonoadipic acid 3-methyl-3-phosphonoadipic acid 4-methyl-3-phosphonoadipic acid 5-methyl-3-phosphonoadipic acid 30 3,5-dimethyl-3-phosphonoadipic acid 3,4-dimethyl-3-phosphonoadipic acid 2,5-dimethyl-3-phosphonoadipic acid 3,5,5-trimethyl-3-phosphonoadipic acid 2,3,5,5-tetramethyl-3-phosphonoadipic acid 5 An example of a compound when m and N = 0 is 2,4,4-trimethyl-2 phosphonoglutaric acid.
Preferred compounds of formula I are those in which RI, R 4, and R 6 are hydrogen Especially preferred compounds are those in which RI, R 4 and R 6 are hydrogen and R 2, R 3 and R 5 are methyl, namely 2,4,4-trimethyl-2phosphono 10 adipic acid, 3,5,5-trimethyl-3-phosphonoadipic acid and 2,4,4-trimethyl-2phosphono glutaric acid or mixtures thereof in any proportion.
Other valuable mixtures of compounds of formula I are a mixture of 2methyl2-phosphonoadipic acid and 3-methyl-3-phosphonoadipic acid, and a mixture of 2,4-dimethyl-2-phosphonoadipic acid and 3,5-dimethyl-3-phosphonoadipic acid 15 A further valuable mixture consists of 3-phosphonoadipic acid of the present invention together with 2-phosphonoadipic acid.
The water-soluble inorganic salts of the compounds of formula I may be the alkali metal salts, for example the sodium and potassium salts and the ammonium salts 20 The water-soluble organic salts of the compounds of formula I may be the salts of amines, for example, mono-, di or triethanolamines.
The present invention further provides a process for the preparation of a compound of formula I where N is I or 0, N is 0, R’, R 2, R 3, R 4, R 5 have their previous significance which comprises reacting a compound having the formula: 25 H R 2 R 4 II X 100 C XCXC-u= O I R 1 m R 3 wherein X’ is C,-C 4 alkyl, m is 1 or 0 and R’, R 2, R 3, and R 4, have their previous significance, with a trialkyiphosphonoacetate having the formula:
coox 2 / c H 2 \p_ O III wherein X 2, Z’ and Z 2 are C, C 4 alkyl in the presence of a condensation catalyst, 30 conveniently a mixture of titanium tetrachloride and a tertiary amine such as Nmethylmorpholine, to give an olefin having the formula:
H R 2 R 41 COX 2 IV Rm R 3 /== R /1 ozi 1,572,406 followed by catalytic hydrogenation to give a compound having the formula:
H R 2 R 4 COOX 2 o X 100 C C CH-CH VR 1 im R 3 lo v oz 1 oz 2 and optionally methylating compound (V) in the presence of a base to give a compound having the formula:
H R 2 R 4 ICOX 2 v oox 2 o X 100 C C C-CH-C-CH 3 VI 5 R 1 m R 3 P 3 O ozi az 2 where, in the compounds of formulae IV, V and VI, X’, X 2, Z’ and Z 2 are C,-C 4 alkyl and R’, R 2, R 3, R 4, and m have their previous significance.
The methylating agent may be, for example, dimethyl sulphate or a methyl halide such as methyl iodide and the base is conveniently sodium hydride.
0 Subsequent hydrolysis of Compound V or Compound VI with aqueous acid or 10 base gives the compounds of formula I in which m is I or 0, N is 0, and R 1, R 2, R 3, R 4, and R 5 have their previous significance The water soluble inorganic or organic salts may be obtained by neutralisation or partial neutralisation of these acids.
The present invention further provides a process for the preparation of a compound of formula I where m is 1, N is 0, R 2 is hydrogen, R 1, R 3, R 4, and R 5 have is their previous significance, which comprises reacting a substituted alkyl halide having the formula:
R 1 R 3 H R 1 I II X 100 C-C-C-C-X VII R 4 wherein X is bromo or chloro-, X’ is C 1 C 4 alkyl and R’, R 3 and R 4 have their previous significance, and the anion formed by treating a compound having the 20 formula R 5 I VIII CH-COOX 2 V I P Oa Z a az az 2 wherein X 2, Z’ and Z 2 are C 1-C 4 alkyl and Rs has its previous significance with a 1,572,406 strong base such as sodium ethoxide to give a compound having the formula:
R’ R 3 H R 5 Xioo CC= C-CC l COOX x I 4 I R PO OZ OZ followed by catalytic hydrogenation to give a compound having the formula:
R 1 R 3 H R 5 I I I X 100 C – CH-G I -COOX 2 H R 4 P -O oz 1 \oz 2 OZ OZ 2 where, in the compounds of formulae IX and X, XI, X 2, Z 1 and Z 2 are C,C 4 alkyl and R’, R 3, R 4, and R’ have their previous significance.
Subsequent hydrolysis of the compound of formula X with aqueous acid or base gives the compounds of formula I in which m is 1, N is 0, R 2 is hydrogen, R’, R 3, R 4, and R 5 have their previous significance The water soluble inorganic or organic salts may be obtained by neutralisation or partial neutralisation of these 10 acids.
The present invention further provides a process for the preparation of a compound of formula I when m is 0, N is 1, and R 2, R 3, R 4, R 5 and R 8 have their previous significance which comprises reacting an olefin having the formula:
R 2 H Rs I I I X 100 OC-C C C = C-COOX 2 XI i 5 I I I R 3 R 4 R 6 wherein X’ and X 2 are hydrogen or C,-C 4 alkyl and R 2, R 3, R 4, R 5 and R 6 have their previous significance, with a compound having the formula:
Zl O 0 Z’O Z 20/PH XII or 2 POZ 3 XIII z 20/ Z 2 00 wherein Z’, Z 2 and Z 3 are C 1-C 4 alkyl to give a compound having the formula:
R 2 H Rs H I I I I X 1 OOC C C C COOX 2 XIV 20 II I I R 3 R 4 P = O R 6 O Zt OZ 2 wherein R 2, R 3, R 4, R 5, R’ have their previous significance, X’ and X 2 are hydrogen or Cl-C 4 alkyl and Z 1 and Z 2 are C,-C 4 alkyl.
Compounds of formula XI can be made by conventional methods.
Subsequent hydrolysis of compound XIV with aqueous acid or base gives the compounds of formula I in which m is 0, N is 1, R 2, R 3, R 4, R 5 and R 6 have their 25 1.572406 previous significance The water soluble inorganic or organic salts may be obtained by neutralisation or partial neutralisation of these acids.
The present invention further provides a process for the preparation of the compounds of formula I wherein m, n, RI, R 2, R 3, R 4, R 5 and R’ have their previous significance by oxidation of a substituted cyclohexanone having the formula: 5 R 1 R 6 R 2 R 4 H wherein RI, R 2, R 3, R 4, R 5 and R’ have their previous significance and Z’ and Z 2 are hydrogen or C 1-C 4 alkyl When either or both Z 1 and Z 2 are C 1-C 4 alkyl, subsequent hydrolysis with aqueous acid or base is necessary to give the compound of formula I The water soluble organic or inorganic salts may be obtained by 10 neutralisation or partial neutralisation of these acids.
The compounds of formula XV are prepared by methods well known in the organophosphorus literature, e g by base catalysed addition of a dialkyl phosphite to the appropriate cyclohex-2-enone.
is Suitable oxidising agents are, for example, concentrated nitric acid, chromic 15 acid/sulphuric acid mixtures, sodium hypochlorite, sodium hypobromite, hydrogen peroxide, peracetic acid and oxygen in the presence of a transition metal catalyst for example cobalt or manganese acetates.
When nitric acid is used as the oxidising agent mixtures of compounds of formula I are usually formed in varying proportions and the individual components 20 may, if desired, be isolated by conventional processes such as fractional crystallisation.
By suitable selection of the conditions under which the oxidation takes place, the proportions of the individual components may be varied.
In this process, when RI, R 2, R 3, R 4, RI and RM are all hydrogen and Z 1 and Z 2 25 have their previous significance 3-phosphonoadipic acid of this invention is formed together with 2-phosphonoadipic acid.
The oxidation with nitric acid may conveniently be carried out using from 20 % to 70 %, preferably from 40 % to 70 % aqueous nitric acid at a temperature from 0 to 1200 C, preferably from 500 C to 70 ‘C, advantageously in the presence of an 30 oxidation catalyst such as a vanadium, manganese or copper compound.
When oxidising a compound of formula XV wherein Z 1 and Z 2 are C, C 4 alkyl with nitric acid, a suitable solvent may be added to aid solubilisation, for example, acetic acid.
The compounds of formula I or salts thereof have been found to impart 35 beneficial properties to aqueous systems to which they are added.
The present invention therefore provides a method of treating an aqueous system with comprises adding to the aqueous system a minor proportion of a compound or mixture of compounds of formula I or their water soluble salts The amount of compound or mixture of compounds of formula I is conveniently from 40 0.1 to 1000 parts, preferably 1 to 1000 parts and most preferably 1 to 50 parts by weight per million parts by weight of aqueous system.
The addition of a compound of formula I, or a water-soluble salt thereof, to an aqueous system, has been found to impart one or more of the following beneficial effects to the treated system: a) the corrosion of ferrous metals in contact with the 45 system is inhibited; b) the precipitation of scale-forming salts of calcium, magnesium, barium and strontium from the treated aqueous system is inhibited; and c) inorganic materials present in the treated aqueous system are dispersed.
The compounds of formula I may be used alone or in conjunction with other compounds known to be useful in water treatment Corrosion inhibitors may be 50 used such as, for example, water soluble zinc salts; phosphates; polyphosphates; phosphonic acids and their salts for example acetodiphosphonic acid, nitrilotris 1,572,406 methylene phosphonic acid and methylamino dimethylene phosphonic acid; phosphonocarboxylic acids and their salts, for example, those described in DTOS 2632774 2, and 3-phosphonobutane 1,2,4-tricarboxylic acid; chromates, for example, sodium chromate; nitrites, for example, sodium nitrite; nitrates, for example sodium nitrate, benzotriazole, bis-benzotriazole or copperdeactivating g benzotriazole derivatives; N-acyl sarcosines; triethanolamines; fatty amines; and polycarboxylic acids, for example, polymaleic acid and polyacrylic acid as well as their respective alkali metal salts.
Dispersing and/or threshold agents may be used, such as for example polymerised acrylic acid and its salts, hydrolysed polyacrylonitrile, polymerised 10 methacrylic acid and its salts, polyacrylamide and copolymers thereof from acrylic and methacrylic acids, lignin sulphonic acid and its salts, tannin, naphthalene sulphonic acid/formaldehyde condensation products, starch and its derivatives, and cellulose Specific threshold agents such as for example, hydrolysed polymaleic anhydride and it salts, alkyl phosphonic acids, 1-amino-alkyl, 1,1diphosphonic 15 acids and their salts and alkali metal polyphosphates, may also be used.
Compounds of formula I may also be used with precipitating agents such as alkali metal orthophosphates, carbonates and hydroxides; oxygen scavengers such as alkali metal sulphites and hydrazine; sequestering agents such as nitrilotriacetic acid and their salts and ethylene diamine tetraacetic acid and its salts; antifoaming 20 agents such as distearylsebacamide, distearyl adipamide and related products derived from ethylene oxide condensations; silicones; and fatty alcohols, such as capryl alcohols and their ethylene oxide condensates.
Biocides may be used such as chlorine, ozone, acrolein, organo sulphur compounds for example methylene bis thiocyanate; dithiocarbamates; chlorinated 25 phenols and bisphenyls, for example, 2,2 ‘-dihydroxy-5,5 ‘-dichlorodiphenyl methane and pentachlorophenol; organometallic compounds for example tributyl tin oxide; and quaternary ammonium compounds.
When the compound of formula I used is 3-phosphonoadipic acid, it may conveniently be used in admixture with 2-phosphonoadipic acid, which mixture is 30 formed by the oxidation of the substituted cyclohexanone of formula XV wherein RI, R 2, R 3, R 4, R 5 and R 6 are each hydrogen and Z’ and Z 2 are hydrogen or C, C alkyl.
The compounds of formula I could find use in e g cooling water systems; steam generating plant; seawater evaporators; and hydrostatic cookers 35 The following Examples further illustrate the present invention Parts and percentages, shown therein are by weight unless otherwise stated Parts by weight bear the same relationship to parts by volume as do kilograms to litres.
Example 1
Diethyl 1,3,3-trimethyl-5-oxocyclohexanephosphonate (B Pt 128-30 /0 6 40 mm.) was prepared by base catalysed addition of diethyl phosphite to isophorone.
Hydrolysis of this ester with c HCI gave 1,3,3-trimethyl-5oxocyclohexanephosphonic acid (M Pt 167-8 C).
22 parts of 1,3,3-trimethyl-5-oxocyclohexanephosphonic acid were added portionwise, over 6 hours, to a stirred solution or 0 05 parts of ammonium 45 metavanadate in 32 parts of 70 % nitric acid at 55-60 C; when the addition was complete the resulting solution was heated at 55-60 C for a further 5 hours, cooled to room temperature, and diluted by the addition of 50 parts of water This solution was evaporated to dryness, the solid residue redissolved in 100 parts of.
water and again evaporated to dryness to give 21 7 parts of a hygroscopic solid 50 which was substantially a 1:1 mixture of 2,4,4-trimethyl-2phosphonoadipic acid and 3,5,5-trimethyl-3-phosphonoadipic acid which had 31 p chemical shifts of-25 and -32 ppm respectively and a minor proportion of 2,4,4-trimethyl-2phosphono glutaric acid having a 31 p chemical shift of -24 ppm.
Example 2 55
Diethyl 1-methyl-5-oxocyclohexanephosphonate (B Pt 130-2 /0 8 mm) was prepared by the base catalysed addition of diethylphosphite to 3-methyl-2cyclohexen-l-one Hydrolysis of this ester with concentrated HC 1 gave lmethyl-5oxocyclohexanephosphonic acid as a viscous oil.
Oxidation of 19 2 parts of the phosphonic acid with 70 % nitric acid, as in 60 Example 1, gave 20 7 parts of an hygroscopic solid which was substantially a 1:1 mixture of 2-methyl-2-phosphonoadipic acid and 3-methyl-3-phosphonoadipic acid which has 31 p chemical shifts of -24 ppm and -32 ppm respectively.
1,572,406 Example 3
Diethyl 1,3-dimethyl-5-oxocyclohexanephosphonate (B pt 120 /0 1 mm) was prepared by the base catalysed addition of diethylphosphite to 3,5dimethyl-2cyclohexen-l-one Hydrolysis of the ester in concentrated HCI gave 1,3dimethyl5-oxocyclohexanephosphonic acid as a viscous oil.
Oxidation of 18 7 parts of the phosphonic acid with 70 % nitric acid, as in Example 1, gave 17 6 parts of an hygroscopic solid which was substantially a 1:1 mixture of 2,4-dimethyl-2-phosphonoadipic acid and 3,5-dimethyl-3phosphonoadipic acid, having 31 p chemical shifts of-25 ppm and -31 ppm respectively.
Example 4
A concentrated aqueous solution of the mixed product from Example I was 10 allowed to stand at room temperature for several days during which time a white solid precipitated This was collected by filtration and dried to give 3,5, 5-trimethyl-3-phosphonoadipic acid (m pt 167-8 C, decomposing, 31 p chemical shift of -32 ppm) which had the following elemental analysis by weight 15 C H P Required for Cg H 170 OPIH 2 O 36 61 6 78 10 50 % Found 36 71 6 66 10 43 % Example S zo Diethyl 5-oxocyclohexanephosphonate (B Pt 142-3 C/0 2 mm) was 20 prepared by the base catalysed addition of diethylphosphite to 2cyclohexen-1-one.
Oxidation of 23 3 parts of the phosphonic ester with 70 % nitric acid as in Example 1, followed by hydrolysis with concentrated hydrochloric acid gave 22 6 parts of a viscous oil which was substantially a 1:1 mixture of 2-phosphonoadipic acid and 3phosphonoadipic acid, having 31 P chemical shifts of-20 ppm and -30 ppm 25 respectively.
Example 6
Ethyl 4-bromocrotonate ( 19 3 parts) was added dropwise at 25-30 C to a solution of the sodium salt of ethyl 2-diethylphosphonopropionate, prepared from 23 8 parts of ethyl 2-diethylphosphonopropionate and 5 3 parts of sodium hydride 30 ( 50 % in oil) in dioxan The resulting solution was heated at reflux for 18 hr, after which time the sodium bromide was removed by filtration and the solution concentrated in vacuo The residual oil was distilled to give 12 7 parts of ethyl 5 carboethoxy 2 diethylphosphono 2 methylpent 4 enoate boiling at 158 /0 2 mm Hydrogenation of 12 parts of this material over 5 % palladium on 35 carbon gave 7 2 parts of diethyl 2-diethylphosphono-2-methyl-adipate boiling at 146-52 C/0 05 mm; subsequent hydrolysis of S parts of this concentrated hydrochloric acid gave 3 7 parts of 2-methyl-2-phosphonoadipic acid as a glassy solid which had a 31 P chemical shift of -24 ppm.
Example 7 40
Ethyl 5 carbomethyloxy 2 diethylphosphono 4 methylpent 4 enoate (boiling at 160 C/0 3 mm) was prepared by reaction of methyl 4 bromo 3 methylcrotonate with the anion of triethylphosphonoacetate in dioxan as in Example 6.
Hydrogenation over 10 % palladium on carbon gave ethyl 5 carbomethoxy 2 45 diethylphosphono 4 methylpentanoate, boiling at 166 C/0 2 mm (Found: P.
8.96 %; C,4 H 280,P required: P, 9 18 %).
Hydrolysis of 10 parts of this material with concentrated hydrochloric acid gave 8 3 parts of 4 methyl 2 phosphonoadipic acid as a glassy solid having a 3 ‘p chemical shift of-20 ppm and the following elemental analysis by weight 50 Found: C, 34 94 %; H, 5 99 % CH 130,P requires: C, 35 01 %; H, 5 46 % Example 8
Ethyl 5 carbomethoxy 2 diethylphosphono 2,4 dimethylpent 4 enoate (Boiling at 160-4 C/0 2 mm) was prepared by the reaction of methyl 4 55 1,572,406 bromo 3 methylcrotonate with the ‘anion of ethyl 2 diethylphosphonopropionate in dioxan as in Example 6.
Hydrogenation over platinum dioxide gave ethyl 5 carbomethoxy 2 diethylphosphono 2,4 dimethylpentanoate, boiling at 146 C/0 1 mm.
Subsequent hydrolysis with concentrated hydrochloric acid gave 2,4dimethyi-2phosphonoadipic acid as a glassy solid, having a 31 p chemical shift of25 ppm and the following elemental analysis by weight:
Found: C, 35 01 %; H, 5 82 %; P, 11 00 % C.H 1507 P H 20 requires: C, 35 29 %; H, 6 25 %; P, 11 39 % Example 9 10
A solution of titanium tetrachloride ( 7 7 parts by vol) in dry carbon tetrachloride ( 18 parts by vol) was added dropwise at 0 C to dry tetrahydrofuran ( 140 parts by vol) To this solution at O oo C was added dropwise a mixture of triethylphosphonoacetate ( 7 9 parts) and ethyl 3-formyl-3-methylbutyrate ( 5 6 parts) s 15 (prepared by the method of G Hopitz et al, Ann 1961, 649, 36) followed by 15 addition of a solution of N-methylmorpholine ( 15 4 parts by vol) in dry tetrahydrofuran ( 26 parts by vol) over 30 min The resulting mixture was stirred at 0 for 22 hr., water ( 50 parts by vol) was added, and stirred at 20-5 for 30 min This was then ether extracted ( 4 x 50 parts by vol) and the bulked ether extracts washed with water ( 2 x 25 parts by vol) and dried over magnesium sulphate The ether was 20 removed by evaporation and the residual oil distilled to give 7 2 parts of ethyl 5 carboethoxy 2 diethylphosphono 4,4 dimethyl pent 2 enoate, boiling at 142-4 C/0 1 mm, as a cis-trans mixture.
Hydrogenation of this ( 10 2 parts) over platinum dioxide catalyst gave diethyl 2 diethylphosphono 4,4 dimethyladipate boiling at 144-6 C/0 1 mm having 25 a 31 p chemical shift of -23 ppm.
Hydrolysis of this ester in concentrated hydrochloric acid gave 4,4 dimethyl 2 phosphonoadipic acid as a glassy solid having a 31 p chemical shift of21 ppm.
Example 10
Diethyl 2 diethylphosphono 4,4 dimethyladipate ( 3 6 parts) (See 30 Example 9) was added dropwise to a suspension of sodium hydride ( 0 6 parts, 50 % in oil) in dry dioxan ( 100 parts by volume) containing methyliodide ( 14 2 parts) over 2 hr at room temperature The resulting solution was stirred at room temperature for 18 hr then heated to reflux for 2 hr, cooled, the solids removed by filtration and the filtrate concentrated in vacuo 35 Distillation of the residual oil gave 3 parts of diethyl 2 diethylphosphono 2,4,4 trimethyladipate, boiling at 137-8 C/0 03 mm having a 31 p chemical shift of -26 ppm and having the following elemental analysis by weight.
Found: C,53 57; H, 8 91; P, 7 85 % C 1,H 33 OP requires: C, 53 67; H, 8 74; P, 8 14 % 40 Hydrolysis of this ester in concentrated hydrobromic acid gave 2,4,4 trimethyl 2 phosphonoadipic acid as a hygroscopic solid having a 31 P chemical shift of-25 ppm.
Example 11
Demonstration of Corrosion Inhibitor Activity of Product of Example I 45 Corrosion inhibitor activity of the product of Example 1 was demonstrated in the following way by the Aerated Solution Bottle Test and using a standard corrosive water made up as follows:
g Ca SO 4 2 H 20 15 g Mg SO 4 7 H 20 50 4.6 g Na HCO 3 7.7 g Ca CI 2 6 H 20 gallons Distilled water Mild steel coupons 5 cms x 2 5 cms are scrubbed with pumice immersed for one minute in hydrochloric acid and then rinsed, dried and weighed 55 The desired proportion of additive combination is dissolved in 100 ml of staelndard corrosive water A steel coupon is suspended in the solution, and the 1,572,406 whole is stored in a bottle in a thermostat at 401 C During the storage period, air is passed into the solution at 500 ml/minute, the passage of the air being screened from the steel coupon; any water losses by evaporation are replaced as they occur with distilled water from a constant head apparatus.
After 48 hours, the steel coupon is removed, scrubbed with pumice, immersed 5 for one minute in hydrochloric acid inhibited with 1 % by weight of hexamine and then rinsed, dried and reweighed A certain loss in weight will have occurred.
A blank test i e immersion of a mild steel specimen in the test water in the absence of any potential corrosion inhibitor, is carried out with each series of tests.
The corrosion rates are calculated in milligrams of weight loss/sq decimeter/day 10 (m.d d) but for convenience the results are shown as percentage protection, which is defined as follows:
Protection = Corrosion rate for blank (in mdd) corrosion rate for sample (in mdd) 15 Corrosion rate for blank (in mdd) The results obtained using 100 parts per million of the product of Examples 1, 2 and 4 are given in Table I.
TABLE I
Product ( 100 ppm) % Protection Product of Example 1 92 Product of Example 2 93 Product of Example 4 86 Example 12 20
Demonstration of dispersant activity for iron oxide To carry out this test a sample of iron oxide is prepared as follows:
An excess of 0 88 ammonium hydroxide solution is added to 500 millilitres of a 4 weight/volume solution of Fe SO 47 H 20 with vigorous stirring The solution is brought to the boil and filtered under reduced pressure through a Whatman No 54 25 filter paper “Whatman” is a Registered Trade Mark The filtered precipitate is washed with hot water several times and then sucked dry The filter cake is dried in an oven at 1050 C for 2 to 3 hours on a watch glass, then ground in a mortar and pestle to a fine powdery consistency.
0 20 grams of this iron oxide are weighed out into a 100 millilitre measuring 30 cylinder, distilled water added up to the 80 millilitre level and the cylinder placed in a water bath at 500 C When the solution has equilibrated at 500 C, 20 millilitres of a solution containing the additive is added and the suspension stirred thoroughly with a glass rod The cylinder is allowed to stand a further 2 minutes, then removed from the water bath and the contents allowed to settle After 20 minutes 35 the optical density of the suspension is measured at 500 nm in a 1 centimetre cell Iri the absence of additive the optical density was 0 35 and in the presence of the product of Example 1, at a weight ratio of 1 part product of Example 1: 20 parts iron oxide, the optical density was 0 78 This demonstrates the ability of the product of Example 1 to keep iron oxide in suspension 40 Examples 13 and 14 Evaluation of scale inhibiting activity The compounds were evaluated as scale inhibitors in a recirculating water evaporative cooling test ring simulating the major features of an industrial cooling system 45 The rig comprises an electrically heated heat exchanger, cooling tower, tower sump, reservoir, and make up and blowdown facilities Feed water to the rig had the following analysis:
1,572,406 I 572 A 06 il p H 7.39 PA nil TA TH 157 ClIn the analytical data, the signification of the abbreviations used is as follows:PA is phenol alkalinity (ppm of Ca CO 3) TA is total alkalinity (ppm of Ca CO 3) TH is total hardness (ppm of Ca CO 3) The operating parameters for the results described were:
Recirculation rate Water Velocity 106 gallons per hour 1.4 feet per second Maximum water temperature Temperature rise through heater Evaporation Rate Concentration factor 1.8 litres per hour 3.0 is The quantity of compound under test necessary to give the required dose level is added to 200 litres of feed water in the make up tank The rig is then filled ( 20 litres capacity) and run until the required concentration factor has been reached.
Constant volume is maintained in the system by means of an automatic level control The heat exchanger is then stripped down and the weight of scale deposited determined After cleaning and reassembling the heat exchanger, the rig is restarted with the blowdown pump switched on and set to maintain the system at a concentration factor of 3 The rig is then operated until 100 litres of feed water have been used The weight of scale deposited on the heat exchanger is then determined.
Two weights of scale are thus obtained for each test, one whilst the rig is being concentrated and the second after a period of operation at the desired concentration factor The results are expressed as a scaling rate, that is, milligrams of scale deposited per litre of feed water added.
The scale deposited in these tests consists mainly of calcium carbonate and the results are given in Table II.
TABLE II
Scaling rate milligrams’ li tre Dose to feed Example Additive ppm solids Concentration Run Nil Nil 32 8 35 1 13 Product of 5 1 5 5 7 Example 1 2 5 8 4 7 5 14 Product of 10 2 4 2 4 Example 4 5 18 3 4 2.5 8 9 2 3 460 C.
C.
1.572406 In

Claims (1)

WHAT WE CLAIM IS:-
1 A compound or mixture of compounds of the general formula:
H R 2 H R 5 /H I \ I I I I HOOC C c-Cl CC-C -COOH I i 3 I I I R 3 R 4 P=O R 6 I 0 O H H in which m and N may be 0 or 1 but both cannot be 1, R’, R 2, R 3,, R, R 5 and R, are independently H or CH 3, and the water-soluble inorganic or organic salts thereof, 5 with the proviso that when m is I, at least one of R’, R 2, R 3, R 4, R’ must be CH 3, and when m and N are both 0, R 2 and R 3 are each methyl and R 4 and R 5 have their previous significance.
2 A compound or mixture of compounds as claimed in Claim 1 in which R’, R 4 and R 8 are hydrogen 10 3 A compound or mixture of compounds as claimed in Claim I or Claim 2, in which R 2, R 3 and R 5 are methyl.
4 A compound or mixture of compounds as claimed in any of Claims 1 to 3, wherein the water-soluble inorganic salts are the sodium, potassium or ammonium salts 15 A compound or mixture of compounds as claimed in any of Claims I to 3, wherein the water-soluble organic salts are the salts of mono, di or triethanolamine.
6 2-Methyl-2-phosphonoadipic acid 7 4-Methyl-2-phosphonoadipic acid 20 8 2,4-Dimethyl-2-phosphonoadipic acid 9 4,4-Dimethyl-2-phosphonoadipic acid 2,4,4-Trimethyl-2-phosphonoadipic acid 11 3-Phosphonoadipic acid 12 3-Methyl-3-phosphonoadipic acid 25 13 3,5-Dimethyl-3-phosphonoadipic acid 14.3,5,5-Trimethyl-3-phosphonoadipic acid 2,4,4-Trimethyl-2-phosphono glutaric acid 16 A mixture consisting of 2,4,4-trimethyl-2-phosphonoadipic acid, 3,5,5trimethyl-3-phosphonoadipic acid and 2,4,4-trimethyl-2-phosphonoglutaric acid 30 17 A mixture consisting of 2-methyl-2-phosphonoadipic acid and 3-methyl-3phosphonoadipic acid.
18 A mixture consisting of 2,4-dimethyl-2-phosphonoadipic acid and 3,5-dimethyl-3-phosphonoadipic acid.
19 A mixture consisting of 3-phosphonoadipic acid and 2-phosphonoadipic 35 acid.
A compound or mixture of compounds of formula I defined in claim 1 substantially as described in any of Examples I to 4.
21 A mixture of 3-phosphonoadipic acid and 2-phosphonoadipic acid substantially as described in Example 5 40 22 A process for the preparation of a compound of formula I claimed in Claim 1 where m is I or 0, N is 0, R’, R 2, R 3, R 4, and R 5 are independently H or CH 3, which comprises hydrogenating catalytically an olefin having the formula:
H R 2 R 4 Co OX 2 X 100 C c -C X’ 1 _OZ 2 R 1 m R 3 0/1 \OZ 2 to give a compound having the formula:
lo 1,572,406 H R 2 R 4 COOX 2 \ 1 i I X OOC100 C c CH-CH R 1/mF 3 p=o v /1 oz 1 OZ 2 and optionally methylating compound (V) in the presence of a base to give a compound having the formula:
H R 2 R 4 f OOX 2 X 100 C C C-CH-C-CH 3 VI I 1) I 3 3/P=O oz \oz 2 where in the compounds of formulae IV, V and VI, X’, X 2, Z 1 and Z 2 are C, C 4 5 alkyl and R’, R 2, R 3, R 4, and m have their previous significance and subsequently hydrolysing the compound of formula V or VI with aqueous acid or base and optionally neutralising or partially neutralising to obtain the watersoluble inorganic or organic salts.
23 A process as claimed in Claim 22 in which the olefin having the formula IV 10 is prepared by reacting a compound having the formula:
I I X 10 OCXC C =O II R 1 m F 3 wherein XI is C, C 4 alkyl, m is O or 1 and R’, R 2, R 3 and R 4 are as defined in claim 22, with a trialkylphosphonoacetate having the formula:
coox 2 / CH 2 pi= O III 1 Hi 15 oz oz 2 wherein X 2, Z’ and Z 2 are C 1-C 4 alkyl in the presence of condensation catalyst.
24 A process as claimed in Claim 23 in which the condensation catalyst is a mixture of titanium tetrachloride and N-methylmorpholine A process as claimed in any of Claims 22 to 24 in which the methylating agent is methyl iodide.
26 A process as claimed in any one of Claims 22 to 25, in which the base is 20 sodium hydride.
27 A process for the preparation of a compound of formula I claimed in Claim 1, where m is 1, N is 0, R 2 is hydrogen, R’, R 3, R 4, and R 5 are independently H or CH 3, which comprises hydrogenating catalytically a compound having the formula: 25 1,572,406 13 1,572,406 13 Rl R 3 H Rs I I I t X’100 CC =C C -C-COOX 2 IX I I R 4 P=O o ZI OZ 2 to give a compound having the formula:
R 1 R 3 H Rs t I I I X’OOC-CH-C C C COOX 2 X I I I H R 4 P =O o/z O oz 2 wherein in the compounds of formulae IX and X, X’, X’, Z’ and Z 2 are C 1C 4 alkyl and R 1, R 3, R 4, and R 5 have their previous significance and subsequently hydrolysing the compound of formula X with aqueous acid or base and optionally neutralising or partially neutralising to obtain the water-soluble inorganic or organic salts.
28 A process as claimed in claim 27 in which the compound of formula IX is prepared by reacting a substituted alkyl halide having the formula: 10 R R 3 H I I i X 100 C C=C C-X VII I R 4 wherein X is bromo or chloro-, X’ is C 1-C 4 alkyl and R 1, R 3, and R 4 are as defined in claim 27, and the anion formed by treating a compound having the formula:
Rs I CH -COOX 2 VIII 1 i I 15 P = O O Zi OZ 2 wherein X 2, Z’ and Z 2 are C 1 C 4 alkyl and R 5 is as defined in claim 27 with a strong base.
29 A process as claimed in Claim 28, in which the strong base is sodium ethoxide.
30 A process for the preparation of a compound of formula I claimed in Claim 20 1, when m is 0, N is 1, R 2, R 3, R 4, R 5 and R’ are as defined in Claim 1, which comprises reacting an olefin having the formula:
R 2 H Rs I I I X 1 OOC C C -C = C COOX 2 XI I I I R 3 R 4 R 6 wherein X 1 and X 2 are hydrogen or C 1 C 4 alkyl and R 2, R 3, R 4, R 5 and R 6 have their previous significance, with a compound having the formula: 25 zlo O Z’O PH XII or / P-OZ 3 XIII Z 20/ z 20 wherein Z 1, Z 2 and Z 3 are C 1-C 4 alkyl to give a compound having the formula:
R 2 H R 5 H I I I i XI()OC _ C: _ C -C _ C _ COOX 2 X 1 V 1 3 14 1 so 16 R 3 R 4 P= 0 R oz OZ 2 wherein R 2, R 3, R 4, R 5 R’ are as defined in claim 1, X’ and X 2 are independently hydrogen or C 1 C 4 alkyl and Z 1 and Z 2 are C, C 4 alkyl, followed by subsequent hydrolysis with aqueous acid or base, and optionally neutralising or partially neutralising to obtain the water soluble inorganic or organic salts 5 31 A process for the preparation of a compound or mixture of compounds of formula I, claimed in Claim 1, wherein m, n, R’, R 2, R 3, R 4, R 5 and R’ are as defined in Claim 1, by oxidation of a substituted cyclohexanone having the formula:
R 1 R 6 O oz 7 10 R 5 OZ R 4 H wherein R’, R 2, R 3, R 4, R’ and R’ are as defined in Claim 1, and Z 1 and Z 2 are hydrogen or C 1-C 4 alkyl, followed by subsequent hydrolysis with aqueous acid or base when either or both Z 1 and Z 2 are C, C 4 alkyl, and optionally neutralising or partially neutralising to obtain the water-soluble inorganic or organic salts.
S 32 A process as claimed in Claim 31, in which the oxidising agent is 15 concentrated nitric acid, chloromic acid/sulphuric acid mixtures, sodium hypochlorite, sodium hypobromite, hydrogen peroxide, peracetic acid and oxygen in the presence of a transition metal catalyst.
33 A process as claimed in Claim 32, in which the oxidation with nitric acid is carried out using from 40 % to 70 % aqueous nitric acid 20 34 A process as claimed in Claim 32 or Claim 33 in which the oxidation with nitric acid is carried out at a temperature from 501 C to 700 C.
A process as claimed in any of Claims 32 to 34, in which the oxidation with nitric acid is carried out in the presence of an oxidation catalyst.
36 A process as claimed in Claim 35, in which the oxidation catalyst is a 25 vanadium, manganese or copper compound.
37 A process for the preparation of a compound or mixture of compounds claimed in Claim 1, substantially as described in any of Examples 1 to 4.
38 A process for the preparation of a compound or mixture of compounds claimed in Claim 1, substantially as described in any of Examples 5 to 10 30 39 A compound or mixture of compounds as claimed in Claim 1, whenever prepared by a process according to any of Claims 27 to 29 and 31 to 37.
A compound as claimed in Claim 1, whenever prepared by a process according to any of Claims 22 to 26 or 30 to 38.
41 A method of treating an aqueous system which comprises adding to the 35 aqueous system a minor proportion of a compound or mixture of compounds of formula I claimed in any of Claims 1 to 20 and 39 l 42 A method as claimed in Claim 41, in which the amount of compound or mixture of compounds of formula I added is from 1 to 1000 parts by weight per million parts by weight of aqueous system 40 43 A method as claimed in Claim 41 or Claim 42, in which there are also added one or more other corrosion inhibitors, dispersing and/or threshold agents, precipitating agents, oxygen scavengers, sequestering agents, antifoaming agents and biocides.
1,572,406 44 A method as claimed in Claim 41, substantially as described in Example 11 or Example 12.
A method as claimed in Claim 41, substantially as described in Example 13 or Example 14.
46 An inhibited corrosive water system whenever obtained by a method as 5 claimed in any of Claims 41 to 44.
47 An inhibited corrosive water system whenever obtained by a method as claimed in Claim 45.
48 An inhibited corrosive water system, containing a minor proportion of a to compound or mixture of compounds of formula I claimed in any of Claims I to 21 10 and 39.
49 A compound of formula I, or a mixture thereof substantially as described in any of Examples 6 to 10.
A method of treating an aqueous system which comprises adding to the i 5 aqueous system a minor proportion of a compound or mixture of compounds of 15 formula I claimed in any of Claims 21, 40 and 49.
51 A method as claimed in Claim 41 or Claim 50, in which the amount of compound or mixture of compounds of formula I added is from 0 1 to 1000 parts by weight per million parts by weight of aqueous system.
52 A method as claimed in any of Claims 41, 50 and 51 in which the amount of 20 compound or mixture of compounds of formula I added is from I to 50 parts by weight per million parts by weight of aqueous system.
53 A method as claimed in Claim 51 or Claim 52, in which there are also added one or more other corrosion inhibitors, dispersing arid/or threshold agents, precipitating agents, oxygen scavengers, sequestering agents, antifoaming agents 25 and biocides.
54 An inhibited corrosive water system whenever obtained by a method as claimed in any of Claims 50 to 53.
An inhibited corrosive water system, containing a minor proportion of a compound or mixture of compounds of formula I claimed in Claim 40 30 T SHARMAN, Agent for the Applicants.
Printed for Her Majesty’s Stationery Office by the Courier Press, Leamington Spa, 1980.
Published by the Patent Office, 25 Southampton Buildings, London, WC 2 A l AY, from which copies may be obtained.
1,572,406

GB54106/76A
1976-12-24
1976-12-24
Aliphatic phosphonic/carboxylic acid compounds

Expired

GB1572406A
(en)

Priority Applications (8)

Application Number
Priority Date
Filing Date
Title

GB54106/76A

GB1572406A
(en)

1976-12-24
1976-12-24
Aliphatic phosphonic/carboxylic acid compounds

DE19772756678

DE2756678A1
(en)

1976-12-24
1977-12-20

CHEMICAL COMPOUNDS AND PROCEDURES FOR THEIR PRODUCTION

FR7738948A

FR2375245A1
(en)

1976-12-24
1977-12-23

CARBOXYPHOSPHONIC ACIDS USABLE FOR WATER TREATMENT

NL7714372A

NL7714372A
(en)

1976-12-24
1977-12-23

PHOSPHONICARBONIC ACID DERIVATIVES AND PROCESS FOR THE PREPARATION OF SUCH COMPOUNDS.

BE183802A

BE862274A
(en)

1976-12-24
1977-12-23

CARBOXYPHOSPHORIC ACIDS USABLE FOR WATER TREATMENT

JP15633277A

JPS5379822A
(en)

1976-12-24
1977-12-24
Phosphonoocarboxyl hybrid acid derivatives process for preparing same and aqueous system treating method using same

US06/015,016

US4208344A
(en)

1976-12-24
1979-02-26
Phosphonoadipic acid additives to aqueous systems

US06/087,133

US4265769A
(en)

1976-12-24
1979-10-22
Method of treating aqueous systems with phosphonoadipic acids

Applications Claiming Priority (1)

Application Number
Priority Date
Filing Date
Title

GB54106/76A

GB1572406A
(en)

1976-12-24
1976-12-24
Aliphatic phosphonic/carboxylic acid compounds

Publications (1)

Publication Number
Publication Date

GB1572406A
true

GB1572406A
(en)

1980-07-30

Family
ID=10469928
Family Applications (1)

Application Number
Title
Priority Date
Filing Date

GB54106/76A
Expired

GB1572406A
(en)

1976-12-24
1976-12-24
Aliphatic phosphonic/carboxylic acid compounds

Country Status (7)

Country
Link

US
(1)

US4265769A
(en)

JP
(1)

JPS5379822A
(en)

BE
(1)

BE862274A
(en)

DE
(1)

DE2756678A1
(en)

FR
(1)

FR2375245A1
(en)

GB
(1)

GB1572406A
(en)

NL
(1)

NL7714372A
(en)

Cited By (2)

* Cited by examiner, † Cited by third party

Publication number
Priority date
Publication date
Assignee
Title

US4681686A
(en)

1984-01-13
1987-07-21
Norman Richardson
Cotelomer compounds

US5011682A
(en)

1990-04-18
1991-04-30
Conopco, Inc.
Hypophosphite-containing cotelomers as antitartar agents

Families Citing this family (8)

* Cited by examiner, † Cited by third party

Publication number
Priority date
Publication date
Assignee
Title

DE2942864C2
(en)

1979-10-24
1986-11-20
Hüls AG, 4370 Marl

Cavitation-inhibiting, frost-proof heat transfer fluid

DE2942903A1
(en)

1979-10-24
1981-05-07
Chemische Werke Hüls AG, 4370 Marl

CAVITATION-RESISTANT, FROST-SAFE COOLING OR HEAT TRANSFER LIQUIDS

GB8412063D0
(en)

1984-05-11
1984-06-20
Ciba Geigy Ag
Compositions containing heterocyclic corrosion inhibitors

US4649025A
(en)

1985-09-16
1987-03-10
W. R. Grace & Co.
Anti-corrosion composition

JP2535999B2
(en)

1987-01-22
1996-09-18
日産化学工業株式会社

Method for the benzylideneation of the α-position of acetonyl phosphonates

GB2213807A
(en)

1987-12-17
1989-08-23
Shell Int Research
Recovery of transition metals from aqueous solutions

JPH0795879B2
(en)

1991-09-10
1995-10-11
オンキヨー株式会社

Speaker edge

CN114394681B
(en)

2021-12-17
2023-11-07
自然资源部天津海水淡化与综合利用研究所
Seawater desalination scale inhibitor and application thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party

Publication number
Priority date
Publication date
Assignee
Title

US2616918A
(en)

1949-03-05
1952-11-04
Union Carbide & Carbon Corp
Production of diesterified phosphono derivatives of ketones

DE1038692B
(en)

1956-11-20
1958-09-11
Huels Chemische Werke Ag

Synthetic detergents and cleaning agents containing organic phosphorus compounds

DE1039692B
(en)

1957-04-27
1958-09-25
Heinz Goch

Method and device for generating a combustible mixture from oil vapor and air

US3714066A
(en)

1970-04-13
1973-01-30
Monsanto Co
Methods of inhibiting corrosion with ethane diphosphonate compositions

DE2217692C3
(en)

1972-04-13
1984-10-18
Henkel KGaA, 4000 Düsseldorf

Complexing agent with polyvalent metal ions

DE2225645A1
(en)

1972-05-26
1974-01-17
Bayer Ag

PROCESS FOR PREVENTING CORROSION AND STONE SETTING IN WATER SYSTEMS

DE2310450A1
(en)

1973-03-02
1974-09-05
Henkel & Cie Gmbh
Phosphonocarboxylic acids as polyvalent metal ions complexants – esp. for softening water

SE400563B
(en)

1973-06-29
1978-04-03
Hoechst Ag

OLIGOKARBOXI-ALKANE-PHOSPHONIC ACIDS

DE2505435C3
(en)

1975-02-08
1980-07-31
Hoechst Ag, 6000 Frankfurt

Use of carboxy-alkane compounds of phosphorus as corrosion inhibitors

FR2314193A1
(en)

1975-06-10
1977-01-07
Sturtz Georges

DINITRILS, DIAMINES, PHOSPHONATE DIACIDS, THEIR PREPARATION PROCESS AND THEIR APPLICATION TO POLYCONDENSATION REACTIONS

US4052160A
(en)

1975-07-23
1977-10-04
Ciba-Geigy Corporation
Corrosion inhibitors

1976

1976-12-24
GB
GB54106/76A
patent/GB1572406A/en
not_active
Expired

1977

1977-12-20
DE
DE19772756678
patent/DE2756678A1/en
not_active
Withdrawn

1977-12-23
NL
NL7714372A
patent/NL7714372A/en
unknown

1977-12-23
BE
BE183802A
patent/BE862274A/en
not_active
IP Right Cessation

1977-12-23
FR
FR7738948A
patent/FR2375245A1/en
active
Granted

1977-12-24
JP
JP15633277A
patent/JPS5379822A/en
active
Pending

1979

1979-10-22
US
US06/087,133
patent/US4265769A/en
not_active
Expired – Lifetime

Cited By (2)

* Cited by examiner, † Cited by third party

Publication number
Priority date
Publication date
Assignee
Title

US4681686A
(en)

1984-01-13
1987-07-21
Norman Richardson
Cotelomer compounds

US5011682A
(en)

1990-04-18
1991-04-30
Conopco, Inc.
Hypophosphite-containing cotelomers as antitartar agents

Also Published As

Publication number
Publication date

NL7714372A
(en)

1978-06-27

BE862274A
(en)

1978-06-23

JPS5379822A
(en)

1978-07-14

FR2375245A1
(en)

1978-07-21

FR2375245B1
(en)

1980-02-15

DE2756678A1
(en)

1978-06-29

US4265769A
(en)

1981-05-05

Contact information